Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act - Barron's
Top stories - Google News ·
Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act Barron's Pfizer hikes full-year outlook as newer products grow, taps company veteran as new CFO CNBC Pfizer delivers Q3 beat as post-COVID comeback gains momentum Fierce Pharma Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results Reuters Pfizer increases annual profit forecast amid solid demand for blood thinner drug Yahoo Finance